Evaluating the Safety and Efficacy of AMOR-1 as a Treatment for Hypocalcemia Associated With Hypoparathyroidism in Adults
Conditions
Hypoparathyroidism
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Assuta Ashdod medical center, Ashdod, Israel, Israel
Contact: Principal Investigator (Lior Tolkin, M.D)Hadassah Ein Kerem Medical Center, Jerusalem, Israel, Israel
Contact: Principal Investigator (Rivka Dresner Pollak, MD)Rabin Medical Center, Belinson Campus, Petah Tikva, Israel, Israel
Contact: Principal Investigator (Ilan Shimon, MD)Gloria Tsvetov, M.D (Sub-investigator)Barzilai Medical Center, Ashkelon, Israel
Soroka Medical Center, Beersheba, Israel
Contact: Study coordinator (Tohar Abitbul, Study Coordinator) · toharabi@clalit.org.il · 972-8-6244523Contact: Principal Investigator (Merav Fraenkel, M.D)Uri Yoel, M.D (Sub-investigator)Nuphar Vinegrad, M.D (Sub-investigator)Rambam Medical Center, Haifa, Israel
Contact: Principal Investigator (Sagit Zolotov, M.D)Ghidaa Ayada, M.D (Sub-investigator)Sheba Medical Center, Ramat Gan, Israel
Contact: Study coordinator (Shiran Shalem, Study Coordinator) · shiran.shalem@sheba.health.gov.il · 972-545505460Contact: Principal Investigator (Liana Tripto, M.D)Kaplan Medical Center, Rehovot, Israel
Contact: Principal Investigator (Taiba Zornitzki, M.D)Tal Schiller, M.D (Sub-investigator)Viviana Ostrovski, M.D (Sub-investigator)Sorcha Mildiner, M.D (Sub-investigator)
Study leads
Ilan Shimon, MD
Principal Investigator
Principal Investigator